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The brown re~luse spider, Loxosceles reclusa Gertsch ~:µd Mulaik, 
has been found throughout the south central United States (1). Atkins 
et al. (2 ,3) first described the effect of. the venom, of L •. reclusa on -- -· 
rabbits and hypothesized that this spider was the cause of necrotic 
spider bites which were known to occur in the south central '(Jnited 
States. Further studies with Iaboratory animals fiy Smith and ;Micks (4) 
and Morgan (5) f:I..nily established the lethal and necrotic effects of.the 
b,;own recluse spider venom. 
Necrotic lesions in humans attributed to brown recluse envenomation 
have been descriqed by Atkins et al. (3), Dillaha .~ al. (6 ,8), and 
Lessenden and Zimmer (7). At least three dea~hs, two children (7,9) and 
one adult (9,10) have been attributed to the .brown ,recluse spider. 
Dillaha !:.! aL (6) described. the following symptoms of L. reclusa bites. 
Local reactions can include pain, bleb formation, eryt~ema, ecchymosis, 
necrosis ending in eschar and ulcer format:f..on •. The systematic reactions 
may include fever, nausea, malaise, hemolysis, thrombocytopenia and in 
rare cases, death. 
Steroid therapy has been proposed as treatment for brown recl.us,e 
.evenomation by Dillaha !:,! al. (6,8). In a series of .10 rabbita ch&lleng-
ed with equal amounts of pooled venom, intravenous methyl prednisolone 
was seen to protect all three rabbits re~eiving this steroid six hr 
1 
2 
following venom injection. 
Five of six animals receiving the steroid.24 to 48 hr-after the 
challenge died within three days.as did the single untreated control 
(6). Ten human victims of brown reclus.e bites were .treated ~ith ster-
oids. Five did not develop necrotic lesions. The failure of the treat-
ment with the other five was attriQuted to an excessive length.of time 
between bite and treatment (8). 
Recently Berger (11) described two cases of brown recluse envenoma-
tion where the spiders were positively identified. In neither.case did 
necrosis develop. In fact the effects of the bites were compared to 
those of a flea. Neither of the victims had been previously .bitt.en by 
spiders. Two months after envenomatic;m, both showed positive lymphocyte 
transformation to brown recluse venom. When tested at the tim~ of en-
venomation, neither was positive. The assay for transformat~9n was based 
on the fact that only sensitized lymphocytes will transform.into blast 
cells and undergo mitosis. Mitotic rate was assayed by the incorpora-
tion of tritiated thymidine into daughter cells. Berger .fel,t· these data 
indicated that humans could be innnunized against L. reclusa. He also 
felt that steroids were not an effective treatment. The "successes" of 
steroids have been with people who.would have sho~ :ho n.ecrosis. Experi.,.. 
ments in animals with brown recluse spider venom ha;ve.not.supported 
Dillaha's (6) claim of.the effectivenes1;1 of steroids (12,13). .. 
Morgan (5) conducted toxicity studieJ1 of L; reclusa i'll. several ani-
mals. The venom was collec1ted by electrostimulation and pooled in sa-
line. Protein was.quantitated by the spectrophotometric method of Wad-
dell (14). Approximately 70 µg of venom protein was obtained from each 
spider. Twenty five or more µg of venom protein was.found to be lethal 
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to rabbits wh,ether injected intravenously (i.v.) or intraderm.ally (i.d.). 
Skin lesions were produced by as little as 0.1 µg venom i.d •. The lethal 
i.d. dose in guinea pigs was found to be approximately 20 µg. Sublethal 
doses did not generate as large a lesion as was.produced in·rabbits. 
The intraperitoneal (i.p.) lethal dose in mic;:e was found to.be approxi-
mately 15 µg while the venom was, found to be nontoxic to rats.·· Morgan 
(5) and Atkins (3) found both male and female venoms toxic, but Morgan 
(5) reported that males gave only about half the volume of ven9m as did 
the females. 
Norment .and Smith (15) found that brown recluse venom (collected by 
electrostimulation) caused hemolysis in vivo of hemocytes of the conunon 
house cricket, Acheta domesticus. Norment and Vinson.(16) tested the 
effect of the venom on the tobacco budworm larvae, Heliothis virescens. 
All of the fat body was destroyed as was. the striated mus.cl~ .tissue of 
the body wall and the digestive tract. Some changes.in hemolyJ:D.ph pro-
tein of treated specimens were found by acrylamide gel electrqphoresis. 
Grothaus (17) reported that the .brown recluse spider of.t.en "regurgi..-
tated" when biting. Nazhat (18) found thi$ regurgitated material to be 
a definite problem when trying to identify the protein compoµents of L. 
reclusa venom collected by electrostimulation. Polyacrylamide disc gel 
electrophoresis patterns of .the material collected from different spiders 
were highly variable. Grothaus tested the regurgitated material, as well 
as other body fluids, and found them to be nontoxic to mice. 
Buffkin il al. (19) reported that an extract of eggs of Loxosceles 
was nontoxic while that of the eggs of the :black widow, Latrodectus 
hesperus, contained the toxic components of the adult. 
Enzymes such as proteases, hyaluronidase, and phosphodiesterase 
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have been reported as common component$ of spider venoms (20) •. The en-
zymatic activities present in brown recluse venom have been investigated 
quite thoroughly. Na:i:hat (18) reported that L. reclU:sa venom (collected 
by electrostimulation) contained no protease or phospholipase C or D ac-,. 
tivity. Some lipase activity was observed. Hall (21) reported that L. 
reclusa venom (collected by electrostimulation) contained no phoE1pho-
lipase A activity, although some indication of hyaluronidase activity 
was found. Wright~ al. (22) reported protease,, esterase and hyaluroni-
dase activities were present in brown recluse venom (collecte4-by micro~ 
dissection). AlkaliJ;1.e: phosphatase, collagenase and phospholipase A were 
absent. The hyaluronidase activity was-separated from the esterase ac-
tivity by polyacrylamid.e gel electrophoresis~ Kinetic properties of the 
hyaluronidase as· related to enzyme aJ;1.d subs1rl;'ate concentrations ;Were 
investigated and the pH optimum was detepuined -to be 6. ~. _ A rabbit anti-
serum to the venom was develop~.d and was shown to ·inhibit the activity 
of the hyaluronidase in vitro a_nd in ~· 
Denny~ ale (23) reported hemolysis of red blood cells (RBC) in 
vivo and in vitro. In the first series o( test animals, the venom prep-
aration injected (i.v.) was a saline homogenate of dissected venom 
glands. Nine dogs were challenged .with the homogenate of ap,proximately 
1.5 glands per-dog. All dogs showed depressed platelet c,p,µnts, loss of 
reticulocytes and a $light rise in plasma hemoglobino The 'b,e.matacrit 
dropped slightly in spite of the fact that all dogs exhibited.severe de":" 
hydration. Four dogs were injected (i.v.) with venom obtained by elec-
trostimulation in a second experiment. Each dog-received 37 .µ_g of venom 
protein as measured by the method of Wadden·· (14) • Two -- of the four dogs 
died. The remaining pair exhibited mild hemolysis. The effect,of venom 
5 
collected by electrostimulation was tested in \l'itro with human RBC. 
After 48 hr tv;ro ml of human blood shotved 26 percent hemolysis with 3.7 
µg of venom.protein while controls showed only two percent. No descrip-
tion of the treatment of the blood before hemolysis tests were begun was 
included in the paper. Heating of the serum to inactivate complement 
prior to starting the hemolysis tests resulted in no loss of activity. 
On the basis of the above data Denny.!:..:!:.!!..· have proposed that brown re-
cl.use spider venom has a direct hemqlytic action on red blood cells. 
Smith and Micks (4) investigated the hemolytic properties of three 
species of Loxoxceles, L. laeta, L. reclusa and L. refescens. The venom 
was collected by electrostintulation. An abdominal extract of all three 
was also prepared. Extracts of all three species had a direct hemolytic 
effect on human RBC while venom had none. 
Kniker !:!. al, (24) have reported that L. reclusa venom contains a 
potent inhibitor of hemolytic complement activity~ vitro. This activ-
ity was observed only at .very low venom concentrations as direct hemoly-
sis by the venom became a factor ~t higher concentrations. The assay 
consisted of sensitized sheep erythrocytes with serum added fo.r comple-
ment. The complement inhibitor was found to be nondialyzable, excluded 
fro~ Sephadex G-75, and stable over a wide range of pH, heat, and storage 
conditions. 
Smith and Micks (25) reported that brown recluse lesions are charac-
terized by early and pronounced infiltration of polymorphonuclear (PMN) 
leukocytes. PMN leukocytes in test rabbits were depleted by injecting 
nitrogen mustard. These treated rabbits were t:hen challenged with 1_. 
'. 
reclusa·venom. The venom was collected by electrostimulation and used 
immediately after collection. Depletion of.PMN leukocytes inhibited 
lesion formation in treated animals while control animals developed le-
sions. The effect of complement depletion prior to venom injection was 
tested in guinea pigs and was found to also inhibit lesion formation. 
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On the basis of these experiments Smith and Micks proposed th.at lesion 
formation was due to an "Arthus-like" reaction. Puffer et &· (26) have 
reported that the venom of L. reclusa evoked an "Arthus-like" reaction 
in the microcirculation of mouse gastrolienal mesentery. 
Atkins et al. (3) reported that a single large female rabbit, which 
had been bitten or injected seven times with L. reclusa venom, tolerated 
the injection into. the ear vein of 2 .5 glands macerated in saline. A 
control rabbit died. Both Smith and Micks (4) and Denny et al. (23) re-
ported that multiple injections of L. reclusa venom led to the production 
of serum antibodies. Antibodies were detected by inununodiffusion 
studies. Smith and Micks (4) obtained a Loxosceles antiserum from the 
Institute Butantan, Sao Paulo, Brazil. This antiserum was not produced 
with L. reclusa venom. The venoms of L. reclusa, 1_. refescens, and L, 
laeta were tested with the antiserum by the inununodiffusion technique. 
All three venoms produced three apparently similar precipitation lines. 
Inununoelectrophoresis studies revealed four antigenic compop.ents in all 
three species, but the patterns were distinctly different •. Attempts to 
protect rabbits with three tnl of antiserum injecteq after venom challenge 
resulted in only a very negligible reduction in lesion size. 
Some of the components of 1_. reclusa venom were successfully radio-
labeled by Elgert et al. (27). Spiders were fed 14 C-leu~ine in water. 
Radioactive bands were noted in disc gel electrophoretic patterns of. 
venom collected by microdissection. No correlation of biological activ-
ity to radioactive bands was made. 
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Pinkston (28) has described the morphology of the L. reclusa poison 
apparatus. Based on the observation of secretory packets and cell frag-
ments in the gland lumens, a holocrine secretory process was proposed. 
Several spider venoms have been fr~ctionated by a variety of pro-
cedures. Mccrone and Hatla (29) reported the separation of Latrodectus 
mactans venom into seven components by vertical acrylamide gel electro-
phoresis. The venom of Atrax robustus has been.separated into five com-
ponents by a series of ultrafiltration membranes (30). Schanbacher tl 
al. (~1) described the fractionation of Dugesiella hentzi venom using 
Sephadex G-100 column chromatography. Suarez et al. (32) have fraction-
ated a Loxosceles laeta venom gland extract into two major c.omponents 
using a small (2o2 X 30 cm) G-100 Sephadex column. The slower eluting 
component contained the necrotizing materials (as tested with rabbits) 
and showed only one distinct and two faint bands on polyacrylamide gel 
electrophoresis. In addition the whole extract was reported to contain 
no phospholipase C, collagenase, protease, or phosphodiesterase activity, 
No data were given to support the above statements. 
The objectives of this work were to describe the biological activi-
ties of the toxic components of L. reclusa venom, isolate these compon-
ents, and determine their chemical characteristics. 
The abundance of the brown recluse spider and the toxicity of its 
venom make this study not only desirable, but necessary. 
CHAPTER II 
EXPERIMENTAL ~ROCEDURES 
A. Specimen Collection 
The speci,ens of L. reclusa were collected in central and north-
eastern Qklaho~a and southeastern Kansas. The spiders were.captµred at 
night in individual plastic cups (Premium Plastics, Ir:i.c.). Large numbers 
of specimens could only be ol?tained during the suriuner months.· If the 
spide:i:-s were not used immediately, they were frozen in the cup with dry 
ice, then stored at -15°c until needed. 
B. Dissection of Poison Apparatus 
The entire poison apparatus including chelicerae was dis$ected by a 
slight tnQdification of the method of .Pinkston and Howell*. The modifica-
tion consisteq of freezing the spider with dry ice, then al).owing it, to 
thaw before .. beginning the dissection process. The original _procedure 
was dissection of a live spider. Hemolymph was collected in capillary 
pipets during the dissection process and pooled. 
C. Preparation of .· Extract of 
Poison Apparatus (OXT) 
The extract of the poison apparatus (OXT) was prepared by lightly 
* Personal communication. 
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crushing the apparatuses of 100 spiders, either all female or all male, 
in two ml of 0.02 M NH4Hco3 , pH 8.0, with a flattened glass s.tirring 
rod. The insoluble material was removed by centrifugation at about 7000 
.X g on a Sorvall Model RC-2 at o0 c for 15 min. The supernatant was 
stored at -15°c if not immediately used. All OXT's used for toxicity 
studies were routinely frozen and thawed twice before use. 
D. Determination of Protein 
The protein concentration of the OXT and the various fractions ob-
tained from the OXT were assayed according to the method of Lowry et al. 
(33), using bovine serum albumin as the reference standar4, In the case 
of the highly purified toxins where.little material was available for 
assay, the volumes of the various reagents for the assay were reduced to 
increase sensitivity. Absorbance readings were obtained on a Perkin-
Elmer Coleman 101 Spectrophotometer. 
E. Toxicity Studies 
Toxicity studies of the OXT were conducted with adult A,merican cock-
roaches, Charles River CD-1 Strain white mice, 20.to 25 g, and New Zea-
land white rabbits.. The cockroaches were anesthetized with co2 and in-
jected intra-abdominally by the method described by Grothaus (17). The 
mice were anesthetized with diethyl ether and injected intraperitoneally. 
The rabbits were restrained and injected intraperitoneally. All test$ 
included animals injected wii;'.h Ji3.Qlvent blanks. The Reed-Meunch method 
(34) was used for obtaining 1n50 values. 
The lesion producing ability of the OXT-was approxi?J\ately quanti-
tated using the rabbit skin test of Kondo~!.!.· (35). To test the 
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effectiveness of the OXT in generating a lesion in mice, nine mice were 
injected with doses ranging from 24 to 192 µg protein. All injections 
were made subcutaneously in the upper hind leg. 
A separate group of six rabbits wasused to test the effect of dif-
ferent sites of venom injection. Routes tested were intravenous (ear), 
intraperitoneal, subcutaneous (back) and intramuscular (hind leg), One 
rabbit was injected by each method with the exception of the i.v. route 
wher.e three animals were tested, In all tests 360 µg of OXT protein 
was injected. 
Toxicity of the hemolymph of brown spiders in mice by the i.p. 
route was also tested, 
F. Freeze-Thaw Stability of OXT 
The stability of the OXT to freezing and thawing was .tested by in-
jecting a series of mice with OXT which had been subjected to freeze-
thaw varying numbers of times. The route of injection in each case was 
i.p., and the amount of OXT protein injected in each case was 200 µg di-
luted to 500 µl with 0.02 M NH4Hco3 • 
G, Temperature Stability of OXT 
The temperature stability of the OXT was tested by incubating the 
OXT for 30 min at various temperatures before injecting into mice, 
Again 200 µg of OXT protein was used and the route was i,p. 
H. Effect of Buffer pH and Type on OXT Toxicity 
To test the effect of different pH's and buffers the following 
scheme was used: 100 µg of the OXT (preparation for which LD50 was de-
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termined) was incubated with 300 µl of the buffer to.be tested for two 
hr at o0 c, then it was.injected intr~peritorteally into mice, 
I. Effect of Proteases on Toxicity of OXT 
To test the effect of proteases on the toxicity of the 04T the fol-
lowing experimental procedure was used. The proteases utilized were 
Pronase and trypsin (Calbiochem grade B) and the buffer was Tris, 0,046 
M, pH Sol, containing 0,0115 M CaC12 , In the initial experiment 350 µg 
of OXT was utilized for each test animal, and this amount was preincu-
bated for 30 min at room temperature with 20 µg of protease. In a sec-:-
ond experiment only 180 µg of OXT protein was used and preincubation time 
was one hr, Injections were made intraperitoneally into 20 to 25 g 
white mice. 
J, Protease Assays 
To insure that the proteases used in the above experiment were 
active and to test the protease activity of the OXT the enzyme a,psay 
method of Hummel (36) was usedo The highest amount of OXT protein assay-
ed by this method was 100 µg, In addition, the protease ass~y .of Kunitz 
(37) was used to test the activity of the OXT. Two different .substrates 
were utilized: one percent bovine serum albumin and one percent casein. 
The buffer in both cases was O, 1 M sodium phosphate, pH 7 ,(5,. Incubation 
0 
temperature was. 37 C and aliquots were tal<en for acid-solu.ble protein 
determination at 30 min and four hr. The maximum amount of the OXT 
assayed for protease activity was 120 µg protein per .ml of assay mixture. 
For comparison trypsin was .. tested for protease activity in the sanie sys-
tem. 
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K. Phosphohydrolase Assays 
Phosphohydrolase:activity of the OXT,was deter~ined qy two methods. 
The first method.consisted of measuJ;"ing the free inorganic phosphate 
(Pi) released from nucleotides by the OXT. The method was that of Marsh 
(38). All reagent volui;nes were one-fourth those described by .Marsh. 
The buffer was 100 mM Tris-HCl, five _mM in MgC12; two'mM in KCl and pH 
6. 8. The total volume was, one ml iri each ·assay. · All absorbance readings 
were taken on a Beckman DU Spectrophotomet(;!.r. Roth ATP and G'.I'P- (10-4 11) 
were utilized as substrates. , The second method of phosphohydr.o.lase de-:-
termination was that of Garen and LevinthQl (~9) •. The amount of p-nitro~ 
phenyl phosphate was only half. that ,descJ;'ibed. The amount o·f OXT protein 
assayed.for activity was.SO µg. The-pH.and temperature optima of the 
OXT were established by the.first ai;isay procedure. In both cases 36 µg 
-9 of OXT was used; total sampl,e volume was O. 5 ·ml· and 9· X 10 J'.l ATP was 
used as the substrate. Blanks contained all components inclug;f.ng 36 µg 
·' . . 0 
of OXT protein which had been denatured by heating at 100 C fQ.r five min. 
IIJ. the temperature optimum assays, blarik,s were included.at·e~1;,h tempera-:' 
ture and enzym,e;. re.action time was 90 min. In the pH optimum experiments 
reaction time was 45 min. 
L. Hyaluronidase Assays 
Hyaluronidase assays w;ex-e conducted with both OXT and hemolymph by 
the method of Tolksdorf, ~ al. (40). 
M. Hemolysis Tests 
The hemoly.tic p.roperties .of ...the .'OXT were. inv.es.tig~t.ed .PY·, ._number 
of procedures. In all.cases the red blood.cells (RB<:;) were washe4 with 
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normal saline until no hemoglobin was.apparent in the supernatant then 
the cells were diluted 1:10 with normal saline. The original tes.t solu-
tions contained 0.1 ml diluted R~C, 1.0 ml normal saline and varying 
amounts of OXTo Separate samples were incubated at 24 and 37°C. Ali-
quots of supernatant were taken for hemoglobin determination at 45 min, 
3 hr and 12 hr. The modified benzidine method of Crosby and Furth (41) 
was used to determine hemoglobin release. The same tests were repeated 
with O .1 ml human serum added for complement, A third series was . with 
serum and O. 07 ·· M · Cacl2• The second series of . tests previoµ.sly described. 
was repeated using rabbit RBC and rabb1t serum. In all cases, O, 50, 
100 and 150 µg of OXT were used with duplicates of.each concentration. 
N. Thin-Layer Gel Chromatography 
Initially small amounts of OXT were fractionated by t.he process of 
G-100 thin-layer gel filtration (TLG). The method is that of Radola 
(42). The elutant was 0.02 M NH4Hco3 , pH 8.0. The reference proteins 
were obtained from Pharmacia with the exception of bovine crystalline 
albumin which was obtained from Mann Research Laboratories, .The stand-
ards used to.establish the molecular weight curve were cytochrome C (cyt 
C), myoglobin (myo), chymotrypsinogen A (chymo A), ovalbumin (oval) and 
bovine serum albumin (BSA), The·standard curve was of inverse migratiorl. 
distance (relative to cytochrome C) versus log molecular weight. 
O. Fractionation of OXT 
Ool. Column Chromatography 
The final fractionation procedure o:Et.he OXT consisted of Sephadex 
G-25 and G-100 column chromatography, preparative disc gel electrophore-
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sis, and finally Sephadex c;.;..50 column chromatography. The low molecular 
weight.fraction of the OXT was further separated by Bio-Gel P-2 column 
chromatography with the final.purification of some components being ac-
complished wiih Dowex ion exchange re$in. A flow diagram of the proce-
dure is included in th.e Results Chapter. All fractions were concentrated 
by lyophi],.i~ation. The G-25 col~n was 0.8 X 80 cm and. had a flow rate 
of 5.5 ml/hr. The G-100 column was 1..2 X 60 cni. arid had a flow rate of 
8,.ml/hr. The G-50 column was 2 X 20 cm and had .a flow rate of 30 ml/hr •. 
.in all the above columns the elut,ant was 0.-02 M·NR4Hco3 and ·the volume 
cc;,llected per fraction tJ=as l. l. ml. . The iori exchange ·· reeiri used was 
Dowex 1 X 8 (200-400 mesh) in the formate form. Column sizew~s 1 X 25 
cm and the flow rate was.l ml/min. Fraction size was two ml., The gradi-
ent was.of the two reservoir constant mixing type and is described below. 
E:lut;ion Scheme 
50 ml H2o in lower reservoir 
50 ml H2o 
50 ml 4 N formic acid 
'50 ml 4 N formic acid+ 0.3 N anunonit,11I1 formate 
50 ml 4 N formic acid+ 0.6 N ammoniUJll formate 
50 ml 4 N formic acid+ 0.9 N ammonium formate 
50 ml 4 N formic acid+ 1.0 N ammonium formate 
0.2. Assay of Fractions 
The toxicity of the various fractions was det'e.rmined by bioassay 
with mic~, roaches and rabbits. Combinations of certain fractions were 
also tested for toxicity. The protein components.of the fractions 'tlTel;'e 
aseayed by dis.c gel electrophoresis. 
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0.3. Disc Gel Electrophoresis 
Both the analytical and the preparative disc ge+ electrophoresis 
were by the same method, primarily that of Ornstein (43), The gels, pH 
9.5, were seven percent acrylamide and five mm in diametero. The stack-
ing gels measured 1.5 cm while the separating gels were 10 cm in length. 
The samples were buffered at pH 8.3 and contained 10 percent sucrose and 
tracking dye. Electrophoresis of samples was at four mA/gel with cold 
water circulating through the cooling jacket of' the apparatus.. The water 
was.in a closed system containing a pump and an aluminum coil submerged 
in an ice and water mixtureo In the case of the analytical gels, elec-
trophoresis was.continued until the tracking dye was one cm from the 
bottom of the gel and protein bands were visualized with coomassie blue, 
Certain gels were stained with Schiff's reagent by the method of 
Zacharias et alo (44)o The validity of the method was tested by stain-
ing a.gel containing transferrin (Sigma). In the preparative disc gel 
method, electrophoresis was continued for one hr after the tracking dye 
had eluted from the end of the gel to yield better resolution. Normal 
run times were 3 to 4 hr. Multiple samples were separated with only one 
being stained to give the location of bands. Ma]0r bands were cut from 
the gels, the acrylamide sections crushed with a glass stirring rod and 
0 extracted into 0.02 M NH4Hco3 by stirring in a 4 C cold room for 12 hr, 
The validity of the extraction was tested by electrophoresis. of the in-
dividual isolated fractions. In some cases the homogeneity of the iso-
lated bands was tested by electrophoresis at different pB's and gel con-
centrationso Additional gel types used were pH 4o3, seven percent acryl-
amide, pH 4.3, 15 percent acrylamide and pH 9.5, 15 percent acrylamide. 
Hemolymph samples of both male and female spiders were separated on 
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analytical disc gels and compared to. the patterns of toxic purified frac-
ttons of the OXT. 
P. Quantitation of Protein Using Disc Gel Scans 
A very crude estimation of the amount of protein prese~t,in the 
major bands of analytical gels was accomplished by the following tech-
nique. The gels were scanned at 550 nm on a.Beckman DU Spectrophoto-
meter with a Gilford Model 410 Gel Scannirig Attachment. The scan.pattern 
was cut from the chart paper and weighed, then the major peaks were cut 
from the scan and weighed. From these m:easq.rements the percent per band 
of the total could be approximated. Lowry protein determinations on 
material extracted from these same bands on pre~arative gels were also 
made! 
Q. petermination of Molec~lar Weights 
Q~l. Column Chromatography 
The G-100 column described previously was standardized for molecular 
weight determination. Protein standards us.ed were horse heart cytochrome 
C (California Corporation for Bj.ochemical Research), ca.lf intestine alka-
line phosphatase (Calbiochem grade B}, chymotrypsinogen A,(Si~a) and 
ovalbumin (Sigma). The retention times of chymotrypsinogen .A and oval-
bumin were determined by their absorbance at 280 nm. Cyt;ochrome C was 
determined by its absorbance at 550 nm while alkaline phosphatase was 
determined by its enzymatic act;ivity on p~n.itrophenyl phosphate as de-
termined by the method of Gare~ and Levinthal (39). 
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Q.2. Sodium Dodecyl Sulfate (SDS) Gel 
Electrophoresis 
Molecular weights were also determined by SDS polyacrylamide gel 
electrophoresisc The method is that des.cribed by Weber and Osborn (45), 
The gels were five mm X 10 cm and were 10 percent acrylamide. Electro-
phoresis was at eight mA/gel and the molecula-r weight standards were the 
same as described for TLG. Gels were pre-run for four hr and electro-
phoresis of samples was for four hr. 
R. Isoelectric Focusing 
Isoelectric focusing was accomplished by the method described by 
Haglund (46). The pH range of ampholine utilized was 5 to 8. .An Ampho-
line Column LKB 8101 was used and the material was isoelect-rofocused for 
72 hr and 1.1 ml fractions were collected. The pH of the fractions was 
determined using a Fisher ~odel 320 pH Meter with a microelectrode. 
S. Amino Acid Analysis 
Hydrolysis of protein and dete1;'111ination of amino acid coi:npo.sition 
was by the procedure of Moore and Stein· (47). llydrolysis.wa~ accomplish-
ed with 6 N HCl at 110°c for 22 hr •. Actual analysis was accol)lplished on 
a Beckman Model 120C Amino Acid Analyzer. One tenth µM of norleucine 
was added to each sample prior to hydrolysis. 
Tc Determination of Spectrophotometric and_ 
Chromatogra_phic Characteristics 
of-Nucleotides 
Ultraviolet (UV) spectra were obtained on a Cary 14 recording . . 
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spectrophotometer unless otherwise indicated. Buffers used for nucleo-
tide spectra and solvent systems used in paper chromatography were as 
described in P. L biochemicals' Ultraviolet Spectra Ef 5 '-Ribonucleotides 
(48). All four "Pabst" systems were used in the chromatography and 
nucleotides were visualized by UV quenching. The chromatograms were 
also sprayed with ninhydrin and phosphate sprays (49). All sprays were 
tested with known nucleotides chromatographed in.the Pabst.systems. In 
some cases the nucleotides were hydrolyzed for seven min with l.Q N HCl 
0 at 100 C to produce mononucleotides (50). All reference nucleotides 
were obtained from Sigma. 
U. Luciferase Assay 
The firefly luciferase assay of Strehler and Totter (51) was used 
to assay the ATP content of the low molecular weight fraction of the OXT. 
The validity of the assay was tested with ATP standards. The firefly ex-
tract was purchased from Worthington. 
V. Preparation of Antisera 
Antisera were prepared for the OXT and two purified toxins. Animals 
used for antisera production were adult New Zealand white rabbits. For 
OXT antiserum two rabbits were used. Injections were once a week for 
four weeks. The first two injections contained 7.5 µg OXT protein and 
were placed intramuscularly in alternate hind legs. The third injection 
was 15 µg placed intramuscularly in the hind leg. The last injection 
contained 15 µg and was by the i.p. route. For the purified toxin anti-
sera, toxins were obtained from 64 spiders. Again four weekly spaced 
• 
injections were used. Only one rabbit was used for each toxin antiserum. 
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The first injection for each was 1/7 of the total available isolated 
toxin injected in the hind leg. The second, third and fourth injections 
were 2/7 of the total with the second and third injections being placed 
intramuscularly while the last was.by the intraperitoneal route. All 
rabbits were bled via the ear vein 10 days after the last injection. The 
blood was allowed to stand overnight at 4°c then the sera were separated 
by centrifugation. 
W. Detection of Antibodies: 
in vitro and in vivo --
The presence of antibodies was detected by three technique·s: Ouch-
terlony, inununoelectrophoresis and a RBC agglutination method. The 
Ouchterlony and immunoelectrophoresis techniques were as described by 
Claus.en (52). The support medium for both tests was Ionagar No. 28 
(Golab Laboratories). The buffer was 0.05 M veronal and electrophoresis 
apparatus and gel punch were purchased from Gelman. Electrophoresis was. 
for two hr at 80 volts. Visualization of antigen-antibody reactions was 
acc-0mplished with amido black. The agglutination test consisted of coat-
~ng washed human RBC (diluted 1:10 with saline) with antiserum, then 
allowing the coated RBC to react with OXT. Each test solution contained 
0.5 ml saline, 0.05 ml diluted RBC, 0.05 ml antiserum and 25 µg OXT. 
0 Duplicates were run on each antiserum and test were made at 24 and 37 C. 
A second series of tests was with antisera and OXT preincubated together 
for 30 min before adding the RBC. To check for the extent of agglut~na-
tion, a third series of tests with OXT protein varying from 2 to 20 µg 
was conducted. All agglutination tests included controls containing nor-. 
mal rabbit serum. 
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Prior to the generation of antibodies, human, mouse and rabbit sera 
were tested by the Ouchterlony technique for the possible existence of 
natural antibodies.. In addition a mouse skin extract was tested. The 
extract was prepared by homogenizing 1.5 g of mouse skin in 10 ml of 
0.05 M veronal buffer. The insoluble residue was removed by centrifuga-. 
tion. In all experiments 100 µg of .OXT was ·used as the antigen and a 
maximum of 10 µ1 of sera or extract was used as a possible source of 
antibodies. 
The ability of the antisera to neutralize the biological effects of. 
the OXT was tested with mice and rabbit£?. With mice three series of 
tests were conducted. In all three 25 to 30 g white mice were injected 
by the i.p. route. In the first two.tests OXT.was preincubated with an-
tisera before being injected •. In the third test antiserum was injected 
30 min after OXT. With rabbits OXT preincubated with antisera was in-
jected subcutaneously. 
X. Effect of Heparin on OXT Toxicity 
An experi~ent to test the effect of -heparin on the OXT in mice was 
devised. Eight mice were injected intraperit·oneally with 4 .is units 
heparin/mouse prior to being challenged with 300 µg of OXT protein in-
jected i.p~ The second injections.were 30 min after the heparin treat-
ment. Controls included mice injected with heparin alone and venom 
alone. 
Y, Effect of OXT, OXT Frac.:tic:ms and Purified 
Toxins on Plasma Coagulation Time 
To test the effect of OXT and various OXT,componertts on the coagula-
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tion time of plasma, the following experiment was conducted. Plasma was 
separated from out-dated hutnan blood by centrifugation at,1000 X g for 
10 min at room temperature. Since the blood contained citrate to chelate 
+l-
ea , an excess of CaC12 was added. Each aE?say for coagulation time con-
tained 0.5 ml plasma and 0.2 ml one percent CaC12 W/V. Coagulation time 
was,taken as the difference.between the time of addition of CaC12 and 
time of full loss of liquid plasma. All assay mixtures and controls 
were preincupated at 37°c for 10 min prior to the addition of Cacl2 to 
initiate coagulation, 
The first series of tests compared the coagulation time of plasma+. 
CaC12 to that of the same mixture containing 50 µg of OXT protein. Co-
agulation times were also determined for a second set of controls con-
taining volumes of .0.02 M NH4Hco3 and 0.10 M NH4Hco 3 equal to that of 
the OXT. A second series of tests compared controls to assays contatning 
various amounts of OXT. Other tests were conducted to compare the coagu-
lating ability of various fractions and toxins. 
z. Pathological Examinations 
The rabbits used in the LD50 determination were also used for path-
ological examinations. Immediately after death the heart, kidneys, and 
sections of liver, large and small intestines were removed and placed in 
10 percent formalin. The samples (13 rabbits) were given to ·Dr o Billy 
Ward of the Department of Veterinary Pathology, OSU, for microscopic 
histological examination. In addition several series of mice were given 
to Dro Ward after being injected with different amounts of OXT by differ-
ent routes. Skin lesions of rabbits were a+so made available for examin~ 
at ion. 
CHAPTER III 
RESULTS AND DISCUSSION 
A. Specimen Collection, Dissection and 
Preparation of OXT 
Over 5000 spiders have been used in this study. The ease of obtain-
ing specimens indicates the extent of infestation. L. reclusa must be 
considered an important health problem because of the known toxicity of 
its venom. In view of the low egg production and.long development time 
between egg and adult of the brown recluse (53), no attempt.was made to 
rear sufficient spiders for venom fractionation and characterization. 
Several lines of evidence indicated that a whole gland extraction 
process was the best method of obtaining brown recluse venom. This evi-
dence included: Grothaus' (17) observation of spiders "regurgitating" 
stomach contents when biting: Nazhat's (18) findings of the variability 
of. L. reclusa venom obtained by electrostimulation as assayed by disc 
ge+ electrophoresis; and Pinkston's (20) obset;'Vation of secretory packets 
and cell fragments in the lumen of L, reclusa glands and postulation of 
a holocrine secretory process, The possibility of dissecti,ng out the 
glands and squeezing them to collect the venom as described by Wright 
(54) was considered, but was discarded due to the viscosity of the gJand 
contents and the necessity of obtaining the maximum amount of venom, It 
should be noted that the glands were not extensively homogenized in the 
preparation of the OXT. The obvious disadvantage of an extract is that 
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many components of the cells in addition to the venom are also obtained •. 
Biological activities and chemical components of the .extract are signifi-
cant only if they can be directly related to the known toxic properties 
of the venom. ~e work of Grothaus (17) and Nazhat (18) also raises 
another important question; the validity of identification of enzymatic 
and other biological activities in brown recluse venom obtained by elec-: 
trostimulation. The "regurgitated" material may contribute to the 
venom's overall toxicity, but toxic characteristics of the spider bite 
are present in extracts of the poison apparatus only. 
By freezing and thawing the spiders before beginning dissection, 
the muscles of the cephalothorax are fractured from the exo!:!keleton, 
thus allowing the carapace to be removed easily. This simple procedure 
allowed the glands to be removed much more quickly than by t.he original 
method of removing the apparatus from a live spider. Based on extracts 
from 500 spiders, OXT's had an average protein concentration of 5.0 mgkil, 
variation being from 3.6 to 5. 7 mg/ml. These data indicated that about 
100 µg of OXT protein was obtained from the average spider. 
B. Toxicity Tests 
In the determination of LD50 (48 hr) in mice, 44 animijls were used 
with 21 surviving. Figure 1 shows the data obtained treated by the 
Reed-Meunch method (34). Where the two curves cross is the approximate 
w 50 • The value obtained was 4.6 µg OXT/g body weight, Fourteen rabbits 
were used in the LD50 (48 hr) determination with three surviving~ The 
value obtained was 6.0 µg OXT/Kg body weight. In the roach determination 
of LD50 (24 hr) 34 roaches were used with 11 surviving. The value was 30 
µg/roach. Doses of up to 600 µg OXT protein were injected i.p. into rats 
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with no apparent ill effects. The OXT used in rats was tested in mice 
and found to be toxic. Obviously the OXT does not affect all species 
alike. Variations of response within a species have also been reported. 
As Berger (11) has proposed, the severe necrotic lesion in humans may 
represent a very extreme response of a few individuals rather than the 
average response. 
Figure 2 shows the relationship between lesion size in rabbits and 
amount of OXT protein injected as tested by the method of Kondo~ al • 
. , 
(35). Lesion size per µg OXT protein was approximately 0.66 mm. In the 
mouse lesion tests, the five mice with the higher doses died within 48 
hr. The four surviving mice were sacrificed after five days anq. their 
skin was removed and examined. No sign of a lesion was found in either 
dead or surviving mice. Figure 3 shows this lack of skin response in 
the mouse which had the highest dose and survived. 
The method of presenting venom challenge to rabbits has a marked 
effect on OXT toxicity. Of the routes tested, i.p. and s.c. were lethal 
while i.m. and i.v. were not. The i.m. route produced a lesion while 
the i.v. route produced the effect shown in Figure 4. This picture was 
taken 24 hr after injection. No necrosis was ever apparent and even the 
pictured effect wa.s gone within a week. Preliminary experiments with 
mice performed with Dr. Billy Ward indicated that the OXT was equally 
lethal whether injected i.p., s.c., i.v., i.d., or i.m. 
The hemolymph of the spider was found to be essentially nontoxic. 
Only one mouse died, and it had been injected with one mg of hemolymph 
protein. Another mouse injected with the same dose survived. Eight 
mice injected with lesser amounts of hemolymph protein also survived. 
Figure 1. 1n50 (48 hr) of the OXT as Determined in Mice 
The mice were 20-25 g Charles River CD-1 Strain injected 
(i.p.) with OXT diluted to 0.5 ml with 0 • .02 M NH4Hco3• 
The method of interpreting the dat~ is that of Reed 
and Meunch (34). The 1n50 is t;aken as·thepoint of 
intersection of the tw9 curves. Figure 1 shows 4.6 µg 
OXT proteirt/g body weight as the LD50 (48 hr) in mice~ 
Figure 2. Dependence of Lesioh Size in Rabbits on the 
Amount of OXT Protein 
The rabbits used were New·Zealand·Whites·and- the OXT was 
diluted to ·0.2 ml total volume with 0~02:~ mt4Hco3 
prior to injec'tion. The nietliort'·uulized'w~;,tiiat of 
Kondo et al. (3'5).. The raboit'was. sa:crif·ic'e~ 24 hr. 
after injection and the· skin was removed.-• Lesion size 
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Figure 3. Mouse S.ubcutaneo~s Tis.sue at Injection Site of OXT 
The picture was,taken five days ~fter injection. Even though 
the mouse was injected (s.q.) with 96 µg of OXT '· protein, no 
lesion was apparent., 
Figure 4. Rabbit Response to OXT Injected i.v. 
Tµree hundred· sixty µg of·, OXT- protein was in-
. jected via the ear vein. The piet-ur.e was 
.taken 24 hr after injectlori. Thi, only evi-
dence of .response was the areas.of discolor-
ation which also disappeared within a week. 
28 
29 
C. Freeze-Thaw Stability of the OXT 
The OXT is stable to free~ing and thawing as is s.hown by Table I. 
This table also indicates that the OXT may be activated by freezing and 
thawing. This OXT was lower in toxicity than usual as 200 µg should 
have been fatal to all mice. This could represent variation of response 
within a species and it certainly points out.the shortcomings of bio""." 
assays. 
D.. Temperature Stability of Toxicity of the OXT 
As Table II shews, the toxic components of the OXT as assayed with 
mice are inactivated at the higher t~mperatures, Some general observa-
tions should be included heie. The OXT loses toxicity when,·stored at 
4°C. Half-life appears to be approximately one week. Lyophilized OXT 
0 has beett successfully stored at -15 C for several months. 
E. Effect of pH and Buffer Type on OXT Toxicity 
The choice of 0.02 M NH4Hco3 as the buffer for all column separa-
tions, etc., was an obvious one in view of the data in Table !IL It 
does offer some protection against pH change and.it is easily removed by 
lyophilization. · The toxic abHity of the OXT seems fairly stab.le to pH; 
but Tris and phosphate buffers appear to inactivate it. An early attempt 
to use a phosphate.buffer in a column p\J;rifd.cation procedure resulted in 
the loss of toxicity in the OXT of·600 spiders. 
F. Effect of Proteases on.OXT Toxicity 
Tables IV and V show that Pronase and trypsin ho.th decrease the 
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BY TOXICITY IN MICE 
No. of 
















TEMPERATURE STABILITY OF TOXICITY OF OXT TO MICE* 
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*E.ach mouse was injected with 200 µg of OXT protein. 
**Incubation time was 30 min. 
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EFFECT OF VARIOUS BUFFERS* ON TH.E TOXIOITY OF OXT IN MICE 
No. of No. dead 
buffer pH mice injected (i. p.) at 48 hr 
0.1 M sodium acetate 4 6 6 
0.1 M sodium acetate 5 6 4 
0.1 M sodium phosphate 6 6 2 
0.1 M sodium phosphate 7 6 3 
0.1 M tris-HCl 8 6 1 
0.1 M tris-HCl 9 6 2 
O. 02 M NH4HC::o3 8 6 6 
H2o 6 6 
*One hundred µg of OXT was incubated with each buffer for two hr at 
o0 c prior to being injecte~ i.p. into mice. 
TABLE IV 









trypsin + OXT, 










*Conditions were as follows: 350 µg OXT, 20 µg proteases, and 30 
min incubation at_ room temperature. 
TABLE V 
EFFECT OF PROTEASE.S ON OXT TOXICITY IN MICE.: II* 
Ne;,. of Material No. dead 
mice injected injected (Lp.) at 48 hr 
2 OXT 2 
4 trypsin+ OXT 0 
4 pronase + OXT· 1 
*Conditions were as fotlows: 180 µg OXT, 20 µg proteases, and one 
hr incubation at room temperature. 
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of OXT was used because incubation with en~ymes was.in a Tris buffer. 
The second experiment with a lower amount of OXT was conducted to show 
that both Pronase and trypsin destroy toxicity. 
G. Protease Assays 
No protease activity was.detected in the OXT. Figure 5 shows this 
lack of activity and compares the activities of the indicated a111ounts of 
pronase and trypsin in Hummel's assay (36). Figure 6 shows similar re-
sults with the method of Kunitz (37). Wright (22,54) has repprted the 
presence of a protease in brown recluse venom by an assay procedure simi-
lar to that of Kunitz (37). Activity was found only with heat denatured 
casein as the substrate. Over 25 µg of venom was required for activity 
and two hr. incubations were used. Possible explanat:ions. for lack of de-
tection of protease in this study are that the enzyme is denatured by 
freezing and thawing or tha't assay incubation times were insufficient. 
1\lso, .the activity of the enzyme reported by Wr'ight was very low. It is 
possible that the OXT contains a highl,y specific protease for which the 
correct assay conditions have not been determined. 
H. Phosphohydrolase Assays and Preliminary 
C.haracterization of the Enzymatic Activity 
Table VI shows the activity of .the OXT with ATP and GTP while Figure 
7 shows its activity with p-nitrophenyl phosphate. Table VI :i.ndica~es 
that.ATP is a better substrate that GTP.and the reaction rat;:e is still 
fairly linear after 90triin of incubation. F:i.gure 7 shows~ very slow 
hydrolysis of p-riitrophenyl phosphate. Figures 8" and 9 in.4icate crude 
estimations of the pH and temperature optima of the phosphohydrolase 
Figure 5. Protease Assay by tqe Method of Hummel (36) 
Figure 6. Protease Activity (With One ml of One Percent 
Substrate) of the OXT Compared to That of 
Trypsin: 
The assay was conducted by the metho4 of Kunitz (37)~ 
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PHOSPHOHYDROLASE ACTIVITY OF OXT WITH ATP AND GTP* 
Substrate (10-4 M) 30 min incubation 90 min incubation 
Moles fi released/mg QXT/min 
GTP 2.68 x 10-8 2.03 x 10-8 
ATP 0.97 x 10-8 0.98 x 10-8 
*Activity was determined by the release of free Pi by the method de-
scribed by Marsh (38). Each value represents the difference between the 
active mixture and a control with the same components except the OXT had 
been heat denatured. 
Figure 7. Phosphohydrolase Activity of.QXT With 
p-Nitrophenyl·P~osphate 
The assay is that of Garen and L~vinthol (39). The 
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Figure 8. Temperature Optimum of the Phosphohy-
drolase Activity of the OXT 
Assay conditions are described in the procedures 
chapter, page 12. 
Figure 9. pH Optimum of the OXT Phosphohydrolase 
Activity 
Assay conditions are described in the procedures 
chaptert pages 12-13. 
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activity. These.values were determined.to optimize conditions for assays 
on fractions.obtained from the OXT. The sigmoid shape of the phosphohy-
drolase activity curve in Figure 7 may indicate product activation but 
this aspect was not investigated further. It. is int~resting .to note that 
WrJght .. (22) detected no phosphatase activity in venom obtained by micro ... 
dissec tiqn. 
I.. Hyaluronidase AsE?ays 
Hyaluronidase activity wa.s,present in the OXT. Wright (n) has 
characterized this activity extensively an4 no further work, was.attempt.,-
ed other than to correlate the location of hyaluronidase.activity with 
one of the fractions isolated from the .OXT. Ninety' µg· of hemolymph pro-
tein displayed no hyaluronidase activity indicating that the enzyme waf! 
present.in the OXT only. Shanbacher et al~ (31) have suggested that 
hyaluronidase is a spreading factor for other toxic components p~esent 
in venoms. Wright . (22) thinks that hyalur.onidase has a similar role in 
the brown recluse spider. 
J. Hemolysis Tests 
No hemoglobin release was obtained with any o:I; the .24° h~olysis 
tests. A slight amount of hemoglobin was released in.all the 37° assays, 
but the amount.was fairly constant from assay to assay and·h~d·no rela-
tion to the aI\lount of OXT present. ThE: lack of hemolytic ai;tiv:ity is in 
di.rect conflict with the findings of Den,ny et al. · (23) but is ·in agree--..--
ment with Smith and Micks (4). It is important to note that Denny~ al. 
used venom obtained by electrostimulation. 
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K. Thin-Layer Gel Chromatography 
TLG chromatography experiments revealed four major coomassie blue 
positive components in the OXT. The approximate average molecular 
weights of these components were 72,000, 53,000, 35,000, ancl 24,000. 
Resolution of components was not complete, but this partial separation 
indicated that Sephadex column chromatography would be effective in 
fractionating larger quantities of OXT. 
L. Fractionation of OXT and Biological 
Properties of Resulting Fractions 
Figure 10 illustrates the separation achi~v,ed with the G-25 column 
des~ribed earlier. In this particular case the OXT separated.was obtain-
ed from 100 female spiders. The separation'pattern.with male OXT is the 
same. Lethality to mice and rabbi ts and lesion causing ability are in 
the high molecular weight fraction (HMW) ., HMW: is ·a:1so toxic to roaches. 
The low molecular weight fraction (I.MW) ha.d an A280tA260 ratio GJ .• f O. 61 
indicating the possible presence of nucleotides. The HMW had an A280!A260 
value of 1. 40. 
Figure 11 shows the separation of the HMW of 200 femal~ spiders by 
the G-100 column. Fraction III is toxic to mammals (both lesion causing 
and lethal) while IV is toxic to roaches. The data for locali~ation of 
roach toxin(s) is given in Table VII. The amounts of fractions in the 
10 µ1 volumes (Table VII) were approximately equal to the amoµnt of each 
< 
obtained from one spider. Twice the quantity of OXT inJected approxi-
mated the amount obtained from one spider. If the amounts pf protein of 
all fractions are summed, a·value of 91 µg is obtained. Thd.s compares 
well with 104 µg protein obtained from one spider in the OXT used, es-
Figure 10. Separation of OXT on G-25 Sephadex 
The column was 0.8 X 80 cm and had a·flow rate 
of 5 •. 5 ml/hr~ The buffer was _:0.02 M Nir4Hco3 
and the OXT was obt.ained fr0:m 100, ,.female 
spiders. A280 values wer.e oht,ad.ned on a 
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Figure 11. Separation of G-25 HMW on G-100. Sephadex 
The column was 1.2 X 60 cm and had a flew rate of. 8 
ml/hr. The buffe·r was 0.02 M NHi:00:03:.-"::·Absorbance 
vatues.~ere obtained on a Perkin-Elmer Coleman 101 
Spectrophotometer. The G-25 HMW was. obtained from 
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TABLE VII 
TOXIGITY OF OXT·FRAQTIONS TO ROACHES 
No. of Volume Amount No. dead 
roaches Material injected* injecte4 protein at 24 hr 
µg µg 
5 ~25 LMW 10 28 0 
5 G-100 I 10 20 2 
3 G-100 I 15 30 1 
5 G-100 II 10 17 0 
5 G-100 III 10 16 0 
5 G-100 IV 10 9 2 
4 G-100 IV 15 14 4 
3 OXT 10 52 3 
3 Oo 02 M NH4Hco3 15 0 
*All samples were dissolved in 0.02 M NH4Hco3 and injected intr~"."" 
'abdominally into ad1,1lt AmericEl,n Cockroaches. 
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pecially in view of the fact that these fractiqns were obtained from a. 
different OXT. As shown in Table VII, fraction IV contains_toxicity to 
roaches while III is nontoxic. Fraction II contains some toxicity, but 
it does not increase with an i~crease in protein. It should be stated 
that the effect of both OXT and fraction IV is irmnediate pat:alysis of 
the roaches even with sublethal amo1,1nts of protein. Fraction !!_does 
not show this property. 
Figure 12 shows analytical disc gels (coomassie blue s.tain) of G-25 
and G-100 fractions compared to .that.of OXT. Fraction G-100 III showed 
no· bands when stained by the Sc;hif f method (47) while 50- µg of trans-
, 
ferrin was very visible by the same technique. This is. weak evidence 
for the absence o~ glycoproteill,s as majo:i;.- compoµerits of G'."-100, III. A 
scan of the coomassie blue stained analytical gel of fractio-q. III is 
sho~n in Figure 13. The bands were; ·further separated by the preparative 
,.., 
technique. The fast running G-50 column was used to remov~ .. acrylam:i:de 
from the protein obtained from the preparative gels. Figure 14 shows 
such a separation. A220 .was-read.rather than .A280 due to the small 
amount of protein presento Th~ acrylamide must be removed because it is 
toxic and also it interferes with Lowry protein determinations.· 
Toxicity to rabbits was found to be located in. the bap,.ds _ labeled 
... , .. 
toxins 1 and 2 on Figure 13. The remainde; of the bands .. :were nontoxic 
in quantiti,es up to the amount'_ of these components obtain_e.d from 100 
spiders. Figure 15 shows the reproducibilityo:I; preparative g;els of 
different G-:-100 fraction III' s. · Th~ 'gel to the extl;'eme. right is of male 
G.-100 fraction III. A single faint band is apparent between· toxins 1 and 
2 in the male fraction III only. This band (pbtained .from Ji4 'sP'iders) 
was nontoxic to mice. ]iigure-16 shows disc gel patterns of (~rom left 
Figure 12. Disc Acrylamide Gel Electrophoresis.Patterns of 
G-25 and G-100 Fractions Compared to OXT· 
The gels contained (from left to right) G-100 I, 60 µg, 
G-100 II, 50 µg, G-10,0 III,, 50 µg~ G .... 100 IV, 30 µg, G-25 
HMW, 60 µg, G-25 LMW, '90µg, and mer·; so···i.rg: .. 'me gels 
. were pI:f 9 .·5, seven percent acrylamide and elec trophore-
sis was at four mA/ ge.1 for 1. 25 hr. The geb were stain-: 
ed with coomassie blue. 
Figure 13. Scan of Analytical Disc Gel Electrophoresis Pat-
tern of G-100 Fraction III 
The gel was scanned at 550 · nnt' on· a Beckman ntr Spe,ctrophoto-
meter. with a Gilford Model 410 Gel .. Scanri'iµ,g· Attachment o 
The gel was pH 9.5, seven percent a~rylamide and.electro-
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F:i,gure 14. Separation of Acrylamide From a Protein Band 
Cut From a Prepara U ve Disc Gel . 
The column was 2 X 20 cm ~-50 Sephade~ and had a flow rate 
of 30 m1/hr. Elutant was. 0 ... 02.,M,.NH4HCO;i and'.the'· toxin 
was obtained from 64 spider·s. 'A:220 values were obtained 
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Figure 15. Coomassie Blue Stained Gels From Different G-100 
Fraction III Preparative Electrophoretic Sepa-
rations 
The gels were pH 9.5, seven percent acrylamide and electro~ 
phoresiS1_was at four rnA/gel for three hr.' Most gel$ con-
tained approximately 180 µg of.Fraction III protein. 
Figure 16. Comparison of Hemolymph With Toxic G-,-100 Fraction 
III by Disc Gel Electrophoresis 
From left to right the gels contained· 0.5µ1 femal~ hemolymph, 
0~5 ·µl ma.le hemolympli, and.180' µg female G:..;:IC).El"fraction III. 
The gels were plf 9~5-; s,even percent a~rylamide and electro-
phoresis was at four rnA/ge:L for 1.25 hr. The gels were : 
stained with cool\lB,ssie blue. 
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to right) 0.5 µ1 male hemolymph, 0.5 µ1 female hemolymph, and +80 µg of 
f~male G-100 fraction III. Obviously the toxic bands • are absent in the 
hemolymph •. 
Toxin 1 appears to be the lesion causing agent in .rabbi.ts when 
small amounts are injected s.c. Larger.amounts of toxin 1 are lethal.to 
mice (i.p.) and rabbits (Lp~ or s.c,). Table-VIII is a purification 
table of the OXT. including toxicity tests (i ~p.) · in mice. A,s Table VII.I 
shows, the G"'.'100 fraction III represents 17 percent of the, OXT protein 
and retains 41 percent of the original toxicity to m.ice. The secend 
method of quantitating the amount of toxins 1 and 2·using a~alytical disc 
gel scans y:i,elds 138 · µg toxin 2 and 250 · µg tc,xin 1 from the OXT' of 10.0 
spiders. Th,is metho4 is of limited value. Fislibein (55) st.;ltes that 
coomassie blue follows Beerrs Lallt only over a very narre>w,r.ange;and the 
bi.nding of the stain varies with the type of protein. Fishb~:i,n .also pre-
sents data that s.how that less coomassie blue is absorbed by the protein 
t,:he further it migrates in ~P~· gel. Regardless, it.appears t;hat incom-. 
plete extraction has been achieved fr~~ the preparative g~l-s due to the 
very great difference. between Lowry determinations on th,.e ·extracted·. 
toxins an,d scan determinations o,q. the gels. Longer extraction·times 
yielded no incret(lse ·. in extracted protein. The· possibility also .exists 
that the protein of toxins 1 and 2 can not .be accurately quantitated by,,-<:}-------
the Lowry technique. The data on determination of the LD50 of the OXT 
have been presented earlier. Forty mice lltere usec1.for the G,-25 HMW de-
termination with 26 surviving. For the G-100 fractiqn III, 26 ·were used 
'\• 
of which 18 survived. For the purified'toxii,.s'l and 2 only.five 25 g 
m:tce were used for each. The data are sununarized 'in Table IX.· These 
data indicat~ that only to'ltin 1 is lethal to mice. This was not expected 
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TAB~E VIII 
PURIFICATION TABLE OF SPIDER TOXINS* 
Total protein. LD50 in mice lethal Toxicity 
units** retained 
Fraction 
(mg) µg/g 1*)dy weight, % 
OXT 10.0 4.6 2 •. 2 X .103 100 
G-25 HMW 6.2 .4 •. 3 1.4 X 103 64 
G-100 III 1. 7 2.0 3 o. 9 X 10 . 41 
Toxin 1 0.041 -1.0 -41 0.02 
Toxin 2 0.045 ------
*The protein concentrations represent an average of 5 different 
preparations of .100 spiders each; 
. **A lethal unit is defined as the µ~/g LD5 of that fraction and is 













EFFECTS OF TOXINS 1 ANO 2 IN MICE 
























as mice do not develop skin lesions. Mice injected with toxin 2 seemed 
hyperactive for the first hour following injection, but no permanent ef-
feet was seen even though animals were observed for two weeks post-injec-
tion. 
The effect of toxin 1 in rabbits is summarized by Table X. Figures 
17 and 18 show the lesion generated by 28 µg of toxin 1 at 24 hr and 34 
days after injection. The effect of toxin 2 in rabbits is shown in 
Table XI.. The s. c. route was included to reduce toxicity and allow 
lesfon formation. The animal injected with the lowest dose of toxin 2 
exhibited all the symptoms shoi-ni. by earlier rabbits W'ith lethal doses 
other than convulsions and death. These symptoms were also the same.as 
shown by rabbits in the OXT LD50 experiment, The symptoms' include a 
comatose state starting 4 to 6 hr after injection and lasting approxi-
mately six hr. During this time the rabbits exhibit severe diarrhea, 
The rabbits usually die after 12 to 20 hr although some have survived 
almost 48 hr. Death is preceded by violent convulsions. Figure 19 sho-ws 
the site of the 12 µg injectio~ of toxin 2 immediately after deatho Ob-
viously there is no severe reaction of ,the skin to'toxin 2 indicating 
that it is not the lesion causing agent. 
Fractions of OXT·were also approximately quantitated as to lesion 
cal,1.sing activity by the method of Kondo et al. (35).. The data is shown 
in Table XIL Four rabbits were used to obtain these data.. The OXT 
value is based on the average of six induced lesions, while the G-25 HMW 
is on four. Both the G-100 III and toxin 1 values are based on the aver-
age of two lesions.each. Figure 20 is a photograph showing two of the 
I ' 
lesions, generated for Table XII, The Iij?;ht source. was 1;>.~hind the skin. 
The small lesion was due to 18 µg of G-25 HMW while the very large 
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TABLE X 
EFFECT OF TOXIN 1 IN RABBITS 
Toxin 1 Route 
µg (Lowry)* of injection Result 
45 i.p. dead (24 hr) 
20 i.p. dead (7 days) 
28 s.c. l~sion 
10 s.c. small lesion 
*Each amount of purified toxin was injected into a single rabbit. 
TABLE XI 
EFFECT OF TOXIN 2 IN RABBITS 
Toxin 2 Route 
µg (Lowry)* of injection .Result (48 hr) 
25 i.p. dead 
16 i.p. dead 
12 s.c. dead 
6 s.c. survived 
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,TABLE Xl! 
LESION CAUSING. ABl~ITY OF Qµ, AND ISOLATED 
FRACTIO~S IN RABaITS 








1 The vaiue represents ·the average of six lesions induced in a single 
rabbit. 
2The G-25 HMW value represents the awerage of 4 lesions induced in 
two rabbits. 
3The G'":'100 III value represents the average of 2 lesions induced in 
two rabbits. 
4 . 
·The toxil;l. 1 value represents the average of.2 lesions induced in 
two rabbits. 
Figure 17. Effect of Toxin 1 24 hr After Injection 
The rabbit was injected (s.c.) with 28 µg of puri-
fied toxin 1. 
Figure 18. Effect of Toxin 1 34 Days After Injec-
tion 
This is the same rabbit.shown in figure 170 
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Figure 19. ~ack of Skin Reaction in Rabbit With 
Lethal Dose of Toxin 2 
The rabbit was injected (s.c.) with 12 µg of puri-
fie4 toxin 2 and died ].2 hr .after injection •. 
Tqe skin was removed immediately after the rab-
'bit .. died. 
Figure zo. Rabbit.Skin Lesions Generated by G-25 
HMW and G-100 Fraction I.II · 
The lesiot1 pictured on the left was generated by 
18 µg · of HMW protein wh:Lle the lesion on the 




lesion was due to 16 µg of G-100 fraction I!I. The values obtained in 
all rabbit skin lesion tests should be considered as approximations, 
The method has many variables including depth and location of injection, 
intraspecies variation in response to venom, and determination of exact 
size of lesion, 
Figures 21 .and 22 show purified toxin 2 electrophoresed in differ-
ent gel systems. In all toxin 2 appears to be a single band, Attempts 
to prove purity of toxin 1 by the same method were not as conclusive. 
Figure 23 sho¥ts toxin 1 electrophoresed in the same gel syste.m in which 
preparative electrophoresis was accomplished, Toxin 2 was included for 
comparison. Toxin I is very diffuse •. In the other gel systems toxin 1 
gave a very diffuse band or none at all. The· 1ack of a sharp band on 
disc gel electrophoresis of toxin I could be due to its insta,bility 
under.the described experimental conditions. This instability could ac-
count for the drastic decrease, during purification, of lethality in 
mice and lesion causing ability in rabbits. A second possible cause of 
this decrease in toxicity is that ot"h.er components separated from the 
toxin have a synergistic ef:l;:ect on its biological activity, .A third 
possibility, at least with regard to the toxicity of toxin 1 ~n mice, is 
that one of the other components of OXT G-100 fraction III is toxic, but 
is denatured during the process of preparative electrophoresis. 
Numerous problems were encouhtered during the development of the 
isolation procedure for toxins 1 and 2, All column steps :must be main-
tained. at 4°C as toxicity is lost when separation is attempted at room 
temperature. The G-25 column step appears unnecessary. If t:pe OXT were 
placed directly on the G'"'."100 column, the LMW fraction should come ot,tt · in 
the salt peak. This was tried twice (200 spider's OXT each time). Sepa-
Figure 21. Electrophoresis of Purified Toxin 2 
in Different Gel Systems 
Gel systems utilized included (from left to right) 
pH 4.3, seven percent acrylamide, pH 4.3, 15 
percent acrylamide, and pH 9.5, seven.percent 
acrylami<;le. The amount of toxin applied to each 
gel was 1/5 the amount obtained from 64 spiders. 
Electrophoresis was at four mA/gel for lo75 hr. 
Figure 22. Electrophoresis of Purified Toxin 2 
The gel was.pH 9.5, 15 percent acrylamfqe and con-
tained 1/5 the p1,1rified toxin 2 obtained from 
64 spidersq Electrophoreeis was at four mA for 
1.75 hr. 
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Figure 23. Electrophoresis of Purified Toxins 1 
and 2 
The gels were. pH 9 •. 5, seven percent act:"ylamide and 
electrophoresis ~s at four mA/gel for 1. 75 hr. 
The amount of toxi~ applied to each gel was ap-
proximately five µg. 
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ration was similar to Figure 11 with an added salt peak although resolu-
tion was not obtained. Analytical disc gel electroproresis of peaks from 
this separation revealed no toxins 1 or 2. Toxicity (as tested in mice) 
was absent from all-fractions. Evidently some detoxifying component is 
removed during the G~25 separation or insolubilized by the subsequent 
lyophilization.. Solubilization of the G-is ·HMW- pd.or to G-1,PO chroma-
tography does result in a slightly opaque solution indicating some in-
soluble component(s). As mentioned earlier, type 6£ buffer is also im-
portant~ If the electrophoresis apparatus was not cool,ed during the 
preparative electrophoresis step, toxic components were denat~red. 
M. Isoelectric Focusing 
The G-100 fraction III of 400 female.spiders was sepa:c:ated on an 
isoelectric focusing column. Figure 24 sliows the, results. Figure 25 
sho~s analytical disc gel patterns of the following: gel 1.- 30 µg oxr, 
gel 2 ..,.. 30 µg G-:-25 BMW, gel 3 - 30 µg G....;100··rII, gel 4 - a portion of 
isoel.,ectric run fractions · (fso) 71.:...84 ~ gel 5 - isc, 12-23, gel. p - iso 
30-40 and gel 7..,.. iso 41-54. The iso 12..;..23 contains the toxic activity. 
Attempts to separate the ampholine from the protein.by dial..y~ds were 
sl,lccessful with _iso 7h84, but dialysis.of iso 12-23.result;C:!,d in the 
loss o~ biological activity. Disc gel electroph<:>1'esis· of. the dialyzed 
material revealed no bands indicating that the toxins either pound to.or 
passed. through the dialysis me111brane .· Figure 24 indicat~s that the iso-
electric pH of both toxins 1 and 2 is approximatedly 8.3 since both 
toxins 1 and 2 · are found in i.so 12-23. A higher pH range of ~pholine 
migq.t achieve separation of to~in 1 from toxin 2, gut the a!,'110.1Jnt of G-100 
. . . 
fraction III required and the length of time involved were prohibitive, 
Figure 24.. Isoelectrtc Focustng of G-100 Frac-
tion III 
The G-100 fraction III was obtained from 400 fe-
male spiders. The isoelec;tric focusing proce.,... 
dure was that of Haglund (49). Fraction size 
was 1.1 ml. A280 values were obt:a,±1;1.ed on an 
Hitachi Perkin-Elmer Coleman 124 ~,Spectrophoto-
meter. The atii.pholine ·was pH" 5-::8,. .The pH of 
the fractions was determined using a Fisher 
Model 320 pH Meter with a microelectrode. 
Figure 25. Isoelectrofocused Fractions Compared 
to OXT, HMW, and G-100 Fraction 
III by Disc· Gel Electro.pJJ.oresis 
The gels contained the foltowing sampl~s: gel 
1 - 30 µg OXT, gel 2 - 30 µg'c;.,:.25 miw~· gel 3 -
30 ·µg G-'100 ItI, geT 4 - . iso 71:.~4·, gel 5 -
iso 12....:23~ gel 6 -iso 30-40, and gel 7 - iso 
41-54. The gels were pH 9.5, seven percent 
acrylamide and ~lectrophoresis was at four 
mA/gel for 1.75 hr. 
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especially in view of,the difficulty in removing the ampholine. 
N. Molecular Weight Determinations 
The G-100 column was calibrated and the ,mole~ular weights of G-100 
fractions III and IV were determined. Figure 26 shows the plot obtain-
ed. Fraction III had a molecular weight of 32,400 while that of IV was 
6,800. Since IV shows o~ly one distinct and one.faint band on polyacryl-
amide gel electro,phoresis,·Figure 12, the value of.6,800 probably repre-
sents the major component •. 
. SDS polyacrylamide gel electrophoretic determinations of the molecu-
lar weights of purified toxins 1 and 2 revealed molecular wei1gh.ts ·of 
34,000 for both. This is an average value, the cotp.posite of three sepa-
rate experimentso Toxil'.l 1 is.slightly heavier tpan toxin.12, 33,800 to 
34, 200 but it is doubtful if the method is this accura'te, Figure 27 is 
a typical example of one of the SDS experiments.. This particular de-
termination yielded results of 33,000 for both toxins. Incidentally, 
both toxins migrated as a single.band under the conditions of SDS elec-
trophoresis. 
o. Amino .Acid Composition of Toxins 1.and 2 
Table XIII shows the amino acid, composition of toxins 1 and 2. 
C.alculations were based on an average molecular weight of 34,000 for• 
both toxins. The identification of methionine sulfoxide is tentative. 
The toxins used for analyses were isolated from 400 spider~. Analyses 
of toxins from 100 spiders were also accomplished but only,qualitative 
information on the identity of amino acids could be.obtained as peaks 
were too small for accurate integration. The recovery of norleucine from 
Figure 26. Molecular Weight Dete:onination of 
G-100 III and IV by Sephadex 
G-100 Column Chromatography 
'· 
' 
The column was 1. 2 X 60 cm and had · a flow rate 
of eight ml/hr.. The bu,ffe.r was 0 •. 0:2 M NH4Hco3 
and the protein standards were 4etected by the 
procedures described on page 16. 
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Figure 27. Molecular Weight Dete:rm:tnation of 
Toxi'1S 1 and: 2' by SDS -·Polyacryl-
amide Gel Electrophoresis 
The metho4utilized was that of Webe,r and Osborn 
(45). The gels were 5 mm X 10 cm and were 10 
percent acryl~ide. Electrophoresis was at 8 
mA/gel. Gels were pre-run for 4 hr and elec-
trophoresis of.samples was-for 4 hr. Bands 
















AMINO ACID COMPOSITibN1 OF TOXINS 1 AND 22 
Toxin 1 3 Toxin Amino Acids No. of residues 
Lys 9 10 
Arg 17 18 
Asx 54 49 
Thr 22 21. 
Ser 17 20 
Glx 26 31 
Pro 10 13 
Gly 45 36 
Ala 30 31 
~ys 8 9 
Val 24 25 
Met 2 
Ile 15 14 
Leu 23 20 




Methionine trace trace 
Total residues 324 319 
1nue to the small amount of purified toxins obtained, no analysis 
for tryptophan was attempted. 
2 
2Hydro1ysis of protein and ,4eterm.ination of amino acids were by the 
procedures of Moore and Stein (47). Actual analysis wa~ accomplished on 
a Bec~man Model 120C Amino Acid Analyzer. 
:;·_ ! 
3calculations were based on molecular weights of 34,000 for both 
toxins. 
4This is a tentative identification based on retention time. 
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all analyses was approximately 50 percent •. All analyses revealed large 
ammonia peaks probably indicatin~ that not all of the acrylamide was re~ 
moved by the G~50 Sephadex column. 
P. Location of Hyaluronidase and Phos.phohydro-
lase Activities in OXT Fractions 
Figure 28 represents the .determination of location of the phospho-
hydrolase activity. The activity of G·-r-100 IV was not tested. The 
phosphohydrolase activity was present in the greatest amount in·G-100 I. 
Figure 29· .. shows ·a·· similar determination of the location of .hyaluronidase · 
activity. The assay is of the tur&id.im.etric type and a los.s of absorb-
ance.at 540 nm represents hyaluronidase activity. The majori;ty of the 
activity was present in G-100 II.while al~ost no activity !as present in 
I or III. As Tu (56) points out, early researchers working wi.th animal 
venoms postulated that the combination of enzymes (proteases, phosphata-. ' 
ses, hyaluronidase, etc.) was responsible for the toxicity of venoms; 
but, as purification procedures improved, enzymatic activity could be 
separated from the toxic components~ This appears to be tr.ue with the 
brown recluse spider venom at least.with respect to hyaluronidase and 
phospho11iydrolase activities. 
Q. Fractionation and Partial 
Characterization of LMW 
The G-25 LMW was, further investigated for two reasons.. First, as 
Table VIII shows, when LMW is retlloved, total toxicity decreases, and 
second, if LMW is ·not removed, t;oxi~ity is lost., These phenh;m.ena do .not 
necessarily have·to be directly related to the LMW as the loss of.toxic-
Figure 28. Phosphohydrolase Activity of G-"100 
Fractions of OXT 
Phosphohydrolase activity was determined by meas-
uring the release of Pi from ATP. The method 
is described in the procedures chapter, page 
12. 
Figure 29. Hyaluronidase Activity of G-100 Frac-
tions of OXT 
A decrease in turbidity indicates hyaluronidase 
activity. The method utilized was that. of 
Tolksdorf, ~ al. (40) • 
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ity during the G-25 separation could be due to slow denaturation of the 
toxins. A possible cause of the loss of toxicity if the G-25 step is 
omitted has already been discussed. A third reason for study of the LMW 
was its high UV abso.rbance at 260 rtm. Recel;ltly, Chan (57) hai;; found 
th,at adenine nucleotides are major constitt,1~nts of tarantula, Dugesiella 
hentzt, venom.. This investigator was cudous as: to whether nucleotides 
·were present in the LMW. 
Q.1. Luciferase Aesay on G-25 LMW 
The luciferase assay (51) revealed no ATP present;: in the LMW frac-
tion of.100 spiders. Using the absorbs.nee values obtained at 280 and 
260 nm the total amount of nucleotides tested was. estimated t.o .be 375 µg 
by the method and nomograph of Adams (58"). · Figure 30 shows the sensitiv-. 
ity of detection of standard ATP by the lucifera.se method. .The absence 
of ATP i,n LMW was not surprising since t}J.e OXT does contain phosphohy-
drolase activity •. 
Q.2. Toxicity of ,Recombined HMW and LMW 
An attempt.was made to regain the toxicity lost during tb;e G-25 
fractionation bf recombining the HMW an4 LMW and testing t;he toxicity of. 
the combination in mice. Table XIV summarizes the experi;m~nt.and re-
sults. No ·synergistic effect of LM:w on HMW was· apparent. In fact the 
combination seems to be slightly less to~ic than HMW alone •. 
Q.3. Isolation anq..Tentative Identification 
of LMW Components 
Since.the OXT is an extract, the hemolymph of 800 female spiders 
Figure 30. Luciferase Assay .ATP St.;:ind,ard CurvE:! 
The firefly lucifer~se assay of Strehler and 
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OXT from lOO spidei'S was.separated into HMWa.nd L~ by the G-25 
column described in the Procedures Chapter. Each fraction was,dissolved 
in 5 ml of O. 02 M NH4Hco3 • -For :the recombined fractions test, equal. 
volumes of LMW and HMW were combined. prior to injection. The protein 
concentration of the H¥W·solution was estimated by the procedure of 
Lowry ~ &~ (33). 
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was collected for comparison. A hemolymph LMW was separated by use of 
the G-25 column. Both hemolymph and OXTLMW's·werefurther fractionated 
by P-2 column chromatography. These separations are compared in Figure 
31. Both separations show four major components (labeled 1,2,3 and 4 on 
each plot) but only peak 1 is different. The other three peaks were. 
eluted from the P-2 column in identical locations. The OXT LMW was ia9-
lated from 340 female spiders so there is an obvious concentration of 
major components in the OXT, In view of their high concentration in the 
OXT, it was deemed worthwhile to attempt to identify all four major com-
ponents of OXT LMW. 
Figures 32, 33, 34 and 35 show ultraviolet spectra of OXT LMW P-2 
' ~ ' 
peaks 1, 2, 3· and.4 respectively. Table XV lists the spectral data ob-
tained from the UV.spectra of the various peaks plus data on inosine and 
GTP obtained on the same instrument. The location of absorbance maxima 
and minima and the shape of the curves for peaks 1 and 2 indicated the 
probable presence of guanine nucleotides. The calculated data do not 
agree particularly well with GTP, especially at pH 11. Addition of one 
M KCN to peaks 3 and 4 caused.no change in their spectra. The same 
treatment of NAD and deamino-NAD standards produced new absorbance maxi-
ma around 325 nm. This procedure eliminated the possibility of peaks 3 
and 4 containing NAD or NAD analogso The spectral data of peak 3 agreed 
well with that of inosine thus indicating its possible presenc;e. 
Initially thin layer chromatography was trted as a method of further 
fractionating and identifying the four OXT P-2 peaks but was found to re-
quire too much material. The paper chromatography systei:µs described by 
Pabst Laboratories (now called P. L. biochemicals, inc.) (4S) were 
superior. In Pa.bst system III peak 1 had an Rf of O. 33 which is close 
Figure 31. P-2 Column Chromatography. of OXT and 
Hemolymph LMW' s 
The column was 1.5 X 80 cm and had a flow rate of 
six ml/hr. The buffer was 0.02 M NH4Hco3• The 
hemolymph LMW was from 800 female spiders while 
the OXT LMW was obtained from 340 female 
spider so 
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Figure 32. Ultraviolet Spectra of OXT·LMW Peak 1 
All spectra were recorded with a Cary 14. The 
sample size was one ml and the buffers were 0.1 
N HCl, pH 1, 0.02 M sodium phosphate, pH 7, and 
0.002 N NaOH, plt lL The amount of material 
used for each spectra was.that obtained from 
nine spiders. 
Figure 33. Ultraviolet Spectra of O~+ LMW Peak 2 
All spectra were recorded witb a Cary 14. The 
sample size was one ml and the buffers were 0.1 
. N HCl, pH 1, 0.02 M sod::J_um phosphate, pH 7, and 
0.002 N NaOH, pH 11. The amount of material 
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FiSure 34. Ultraviolet Spectra of OXT LMW Peak 3 
All spectra were recorded on a Cary 14. The 
sample siz,e was one ml and contained the amount ' 
of material obtained from 32 spid~rs for each 
spectra. The buffers were 0.01 N HCl, pH 2, 
0.02 M·sodium phosphate, pH 7, and 0.002 N 
NaOH, pH 11. 
Figure 35. Ultraviolet Spec;tra of OXT 1f-1W Peak 4 
All spectra were recorded on a Cary 14. The sample 
size was one ml and contained the amount of 
material obtained from 68 sp~d~rs. The buffers 
were 0.01 N' HCl,. pFl 2 and Q:.02 f1 sodium phosphate, 
pH 7. . 
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UV SPECTRAL PATA* OF OXT LMW COMPONENTS 
Sample pH Amax Amin A280/26.0 A250/260 
·oxT tMW peak 1 1 256" 227 0.68 . 0.94 
OXT LMW peak 1 7 252" 222 0~67 . 1.14 
OXt LMW peak 1 11 253'" 224 o._69 1.11 · 
O:X:T LMW peak 2 1 254 229 0.61 L03 
OXT LMW peak 2 7 255 227 0.63 0.99 
OXT LMW peak 2 11 255 231 0.53 0.97 
OXT LMW peak 3 2 249 223 0.26 1.65 
OXT LMW peak 3 7 249 223 0.28 1.68 
OXT LMW peak 3 11 253'' 225 0.23 1._08 
OXT LMW peak 4 2 250" 225 0.23 1.25 
OX'l' LMW peak 4 7 250 225 0.23 1.20 
Inosine 2 249' 223 0.24 1.50 
Inosine 7 249 ,, 222 0.24 1. 70 
Inosine 11 253' 225 0.18 1.05 
GTP 1 256 228 0 .67 0.95 
GTP 7 252 223 0.64 · 1.18 
GTP 11 258 230 0.60 0.91 
* All data was obtained on a.Cary 14 recording spectrophotometer. 
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to the literature value of 0.34 for guanosine (48). The only stai;,.dards 
included with this separation were GTP (experimental Rf 0. 62 ;. literature 
value 0.61) and ATP (experimental Rf 0.41;_ literature value 0.48). Both 
GTP and peak 1 were eluted from ~he chromatogram with water and again 
their spectra were determined. The results are· listed in Table XVI. · 
The chromatogram contained no ninhydrin positive spots. Phosphate spray 
was not used because the chromatography solvent system contained a phos-
phate buffer. Hydrolysis of GTP. and o~ peak 1 with 1.0 N HCl ,produced 
products which migrated.in Pabst III with R:i's of 0".18'-for-~ydrolyzed 
'GTP arid Oa16 'for hydrolyzed peak 1. Ne:lther hycfrolysis prc;,du~t would 
migrate in Pabst II, indicating that the.product oe hydrolysis was prob-
, .. 
ably GMP. · In Pabst IV the following values were obtained: G.T;e: R = .·.. f. 
0.23, peak I (not hydrolyzed) Rf= 0;22: 'Both gay~.a pesitive phosphate 
test .wp.ile one. ninhydrin positive spot was. found with pe~k 1. 
OXT peak 2 migrated with Rf of 0.35.in Pabst III which again is 
close to the literature value for guanosip.e. When peak 2.was eluted 
from the chromatogram, the spectral-data listed in T~ble XVII.w:erie ob-
tained. The hydrolysate of OXT peak 2 ha,d two quenching col!lpl:Jnents, one 
of which was. immobile and one whicl} had an Rf . the same as $u,anosine as 
revealed by chromatography in Pabst II. Chromatography of unmodified 
peak 2 in Pabst IV gave two UV quenching and five ninhydrin positive 
components. The faster moving quenching compo1:1ertt ·lnad an Rf silJ!,ilar to 
that of GMP (O. 39 as CO'Ql.pared to O. 37) but it,s ,spectrum ha,d 1an irregular 
• I • • 
minim1.1'Ql. at 233 run (pH 1). The spectrum did· s;how the charF1,cteristic 
guanine shoulder at -280 nm. This component d.id not give . .a positive 
phosphate test, but this may have been due to its low concentration. 
The slower.mi.grating quenching component of OXT peak 2 had an Rf .similar 
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TABLE. XVI 
UV SPECTRAL DATA* OF CHROMA.TOGRAPHED OXT P-2 PEAK 1 AND GTP 
Sample pH ). max ). min· 280/260 250/260 
peak 1 1 256 229 0.66 0.99 
GTP 1 256 228 o.~7 0.96 
peak 1 7 252 223 o.67 . Ll8 
GTP 7 253 226 0.65 1.11 
peak 1 11 255 214 0.55 1.00 
GTP 11 255 232' 0.58 0.94 
' *All spectra were obtained on a Hitachi Perkin-Elmer Model 124 
spectrophotometer. 
TABLE XVII 
UV SPECTRAL DATA* OF CHROMA.TOGRAPHED OXT P-2 PEAK 2 AND GTP 
Sample pH ). ·m.ax ""' ). min 280/260 -:··250/260 
peak 2 1 256 228 0.67 1.00 
GTP 1 256 228 0.67 0.96 
peak 2 7 252 i23 0.67 1.18 
GTP 7 253 226 0.65 1.11 
peak 2 11 255 232 0.56 0.97 
GTP 11 255 232"' 0~58 .. 0.94 
*All spectra were obtained on a Hitachi Perkin-Elmer Model 124 
spectrophotometer. 
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to GTP (0.22 to 0.23). Its UV spectrum at.pH 1 was very similar to tqose 
of guanine nucleotides. 
As indicated earlier OXT LMW peak 3 had spectral values very similar 
to inosine~. Chromatography of peak 3 in Pabst III revealed no ninhydrin 
or phosphate positive components~ Peak 3 migrated with an Rf of 0.42 
while inosine had an Rf of 0.43. Chromatography in Pabst I revealed an 
average Rf for both peak 3 and inosine of 0.46. 
Very little of OXT peak 4 was obtained so.chromatograp~y was ac-
complished only in Pabst III. Two UV quenching and one ninhydrin posi~ 
tive C(i)11lponents were present. No standards have been chroritat0graphed 
which gave Rf's similar io those obtained for the unknowns in OXT peak 
4. 
The Dowex column procedure wotked quite well with nuclept;ide knowns 
as is shown by Figure 36. OXT LMW."peak r arid2 ·would.not elu.te from the 
column with the gradient described'indicating that neither. contained.any 
of the co11Dl1on guanine moieties. Peak 1 required 2N a11Dl1onium.formate + 
4N formic acid for removal while peak 2 was. removed by lN N_a-OH after . it 
was not eluted by 2N ammonium formate+ 4N"form.ic acid. P~ak .3 .eluted 
from the column as a single peak in the same location as inoaine. Peak 
4 eluted as a doublet in the H2o portion of the gradient •. · Table XVIII 
sununarizes the spectral properties of these two pea.ks at pH 7 .while . 
Figure 37 shows their spectra. The earliest eluting peak is titled LMW 
P-2 peak 4-1 while the second peak is LMW.P-2 peak 4-2. 
Spectra of the four peaks obta:l,.ned from the hemolymph :(.MW ,by P-2. 
' : . 
column chromatography were a],.mosf id~ntica.1, tQ. thes~ obtained from OX'r 
LMW. No adenine ·moieties were apparent in.either LMW. 
Figure 36. Separation of Standard Nucleotides 
With Dowex 1 X 8 Formate 
The elution scheme is included in the Procedures 
ch~pter, pg. 14. The column was.IX 25 cm and 
had a flow rate of 1 ml/min. Five Ttundred µg 
of e~.oh nucleotide, with the exception of ITP, 
was used. Only 100 µg of inosine was placed 







Fraction number ( 2 ml fractions) 
Figure 37. Ultraviolet Spectra of .the Two Compo-
nents of OXT P-2 Peak 4 
The 2 components were separate4 by Dowex 1 X 8 
formate and spectra were.obtained on a Cary 14, 
The buff er was O. 02 M sodium phosphate, pH 7. 
SElI!1.pl~ size was one ml and.contained the amount 
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SPECTRAL DATA OF COMPONENTS OF LMW P-2 fEAK 4 AT pH 7* 
Sample 
·LMW P-2 peak 4-1 














*Spectra were obtained on a Cary 14 recording spectrophotometer. 
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R. Results of Immunological Experiments 
Antisera to.toxin 1, toxin 2, a1,1d OXT were successfully produced. 
Figure 38 shows the double diffusion reactions of antiserum to toxin 1 
(anti 1), antiserum to toxin 2 (anti 2), antiserum to OXT (anti OXT), 
and normal rabbit.serum in patterns 1, 2, 3 and 4 respectively. In all 
four patterns 80 µg of .OXT was J>laced,.in the center well while the outer 
wells had,20, 40,. 60 and 80 µl of antisera starting in the upper left 
well and reading clockwise. Figure 39 shows essentially the s.a,me thing 
with the exception that pattern 4 contains anti OX'r from the second rab-
bit.. There is an obvious difference .in the antisera obtained from the 
two rabbits. 
Figure 40 shows an attempt to reveal whether the dffferent antisera 
cross react •. All outer wells contained 80 µ1 sera while th~ center well 
·.:,• ' 
contained 80 µg OXT. Wells labeled 1 contained anti 1, 2 anti .2, and 
OXT anti OXTo The results were.inconclusive even though theexp-eriment 
was repeatedo Examination of plates under a microscope :.revealed that 
there is an area of diffuse staining where the bands should touch. 
ImmunoelectrophQresis revealed five bands with the anti QXT while 
anti 1 and anti 2 showed only a single.band. Figure 41 shows the stain-
ed slideso 
The presence of antibodies in all antisera was detected by RBC. 
agglutination.· All test solutions,·incuba.ted at· 24°c· gave ag.glutinaticm 
within two hr while controls without OXT-gave none. Incubati,m at 3,7,0 c 
gE1,ve agglutination with some hemolysis ~ c·ontrols with normal s.e-rum and 
OXT gave no agglutination •. When 'the OXT'rancf' antisera were preincubated 
for 30 min before addit;1.g ·the RBG, V~I'.Y little ~g,glutination o.ccu-rred. 
Al,.l iower a:mounts of O~T down to.and including 2 µg gave almost identical 
Figure 38. Antisera ReactiQns to OXT 
All center wells contained 80 µg of OXT. Pattern 
1 spows an~i 1, pattern 2 anti 2, pattern 3 
anti OXT, and pattern 4 normal rabbit serum. 
From the upper left reading clockwise outer 
wells contained 20, 40, 60, and.SO µ1 sera. 
The support media was Ionagar Noo 2S (Colab) 
and the buffer was O. OS M veronal. · 
Figure.39. Comparison of the Two Anti OXT~s by. 
the Ouchterlony Technique 
Condition~ were the.same as those in Figure 38 ex-
cept pattern 4 contained anti OXT from the sec-
ond rabbit. 
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Figure 40. Cross Reaction Test Between Aptisera 
The center well contained 80 µg OXT while the 
outer wells contained 80 µl antisera. Wells 
'iabeleci 1 contained anti 1; 2 anti 2; and OXT 
anti OXT. 
Figure 41. Immunoelectrophoresi.s o.f Antisera 
The outer wells were filled Btlmes pt:tor to 
electrophoresis.while the slot was filled 
with OXT 4 times after e:(.ectrophl:i.re.sis. The 
slide lab,eled·1 contained anti i jp the wells, 
2 anti 2~ ~.a .OXT a1;1t;i. OXT. Preparation of 
slides and electrophoresis procedure are de-





All of the above tests simply indicate tl;iat antibodies against the 
' ' 
OXT arid toxins 1 and 2 have been suc~essfully produced. 
Tables XIX and XX show the effect of OXT treated with antisera and 
injected into mice. Anti 1 appears to neutralize the toxic effects of 
OXT to mice. The survival of the mice injected with anti 1 at 30 min 
after 275 µg OXT challenge should be noted in Table XX. Even though 
mice protected with anti 1 did survive through the original critical 48 
hr, most died within two weeks of OXT injection. The antisera neutral!-
zation tests in rabbits were inconclusive. In the initi~l experiment 50 
µg of OXT was incubated with 200 µ1· of antisera. All three antisera 
were tested. Ncirie of the rabbits sfiowedany response. The second exper-
iment utilized 300 µg of OXT and 200 µl of antisera. Only anti 1 and 
an.ti 2 were tested. A third· rabbit was injected with 300 µg O){T in 200 
µl saline as a control. All three rabbits· exhibited · similar skin· lesions 
after 10 days~ The failure of antisera in neutralizing le,sion formation 
in rabbi ts could be due to low antibody concentration. The ai;i.tibody 
fraction should be purified from the antisera to increase neutralization 
ability. 
No natural antibodies against OXT were detected in mouse, human or 
rabbit sera or in the mouse skin extract. This seems to rule out an 
"Arthus-like" complex in formation of L. reclusa necrotic lesions. 
The successful production of anti 1 and anti 2 does indicate that 
an antibody affinity column ·for one-step toxin purification might sue-










NEUTRALIZATION OF OXT WITH ANTISE.RA: TEST I* 
Material 
injected (i.p~) 
160 µg OXT 
50 µl_anti 1 
50 µ1 anti 2 
50-µl anti 1 
+ 160 µg OXT. 
50 µ1 anti 2 
+ 16_0 µg OXT 
No. dead. 







The 2 mice that died survived 
over 24 hr. 
All mice we:i:-e de.!!,d within 12-hr. 
*All samples were irtcubated for 30 min at room temperature, then 
diluted to 500 µ1 total volume with 0.02 M tm4Hco3 and injected into 25g 











NEUTRALIZATION bF OXT WITH ANTISERA: TEST II* 
Material 
inj,ected (i.p.) 
500 µl normal 
serum+ 275 µg OXT. 
500 µ,l saline 
+ 275 µg OXT 
500 µ1 anti 1 
+ 275 µg OXT 
500 µl ~nti 2 
+ 275 µg OXT 
500 µ1 a.nt;.i .:oxT 
+ 275 µg OX'l: 
215 µg"mtr; 500 µl 












One,mouse died after 5 days and 
the other after 15 days. 
Surviving mouse died after 4 days. 
Surviving mouse d~ed after 8 dayso 
One mouse died-after 12.days while 
the other was still alive at the 
end "of a 20"day· peri;P-4. 
*Conditions were the same· as.· in te~t I· except that 30 g mice were 
108 
S. Effect of OXT, OXT Fractions and Purified 
Toxins on Plasma Coagulation Time 
Table XX! shows the effect of 50 µg of OXT protein on the coagula-
' 
tion time of plasma. Assays containing NH4Hco3 coagulated.at the same 
time as did the controls_ containing only plasma + CaC12• Table XXII -
shows the effect of various amounts.of OXT while TabTe XXIII compares the 
activities of the vario1,1s toxic OXT fractions. Table. XXV lis.ts the ac-:-
tivities of the two purified toxins while Table XXIV cotnpares ·th~ four 
G-100-fractions~ The ability to"coagula~-~ plasma is associa~ed with the 
toxic fractions.and· specifically witJi toxin 1 althougq toxin 2 does have 
sli.ght activity. 
T. Effect of ijeparin Treatment on OXT 
Toxicity in Mice 
Table XXVI shows the effect of heparin treatment on OXT toxicity in 
m,ice. This was.only a preliminary experiment, but it showed little ad-
vantage for the heparin treatment. Researchers at the University of. 
Missouri have found that heparin treatment preverits lesions _in rabbits 
injected with brown.recluse venom (59). This led to the conclusion that 
'' 
the lesions wer~ caused by a-local blood.clotting phenomen~. The plasma 
cc;,agulating activity as_sociated with toxin 1 provides _addi.tional evidence 
that the cause of the lesion could ·.be due· to .local blood clott.ing. 
_Figure 42 summarizes the_fracti9i.,.atio11 of the OXT and indicates the. 
location of the various biological activities. 
v. Pathological ~xaminations 




























2oxT assays contained 50 µg of OXTprotein in additioh to the 
plasma. Both OXT's and controls were preincubated for 10 min prior to 
the addition of.CaC12 to initiate coagulation. 
3coagulation time was taken as the elapsed time between addition of 
the CaC12 and the loss of all liquid plasma. 




EFFECT OF OXT CONCENTRATION ON PLASMA COAGULATION TIME* 
amot,1.nt 




OXT 100 1. 75 
OXT 50 1. 75 
OXT 5 2.00 
Test II 
Control 3.25 
OXT 5.0 2.25 
OX'I 2.5 2.50 
Test III 
Control 3.50 
OXT 1.0 2.50 
OXT 0.5 2.75 
OXT 0.1 3.25 
*Procedure was the same as in Table xxr. 
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TABLE XXIII 





















2G-25 HMW was the toxic HMW separated from the OXT by G-25 Sephadex, 
3G-100 III was the toxi~ third peak separated from the G-25 HMW by 


















COMPARISON OF THE EFFECT OF G-100 FRACTIONS 
ON PLASMA COAGULATION TIME* 
amount 





1. 7 3.00 





1. 7 2.00 





1. 7 2.00 
0.8 1.50 
0 .9. 2.25 





EFFECT OF PURIFIED TOXINS 1 AND 2 ON PLASMA COAGULATION TIME1 
estimated Coagulation time 
Sample protein2 min 
Test.I 
Control 4.00 
Toxin 1 <l µg 2.00 
Toxin 2 <1 µg 3.25 
Test II 
Control 4.00 
Toxin 1 <l ]lg 2.50 
Toxin 2 <1 µg 3.50 
1Procedure was the same as in Table XXI, 
2Toxin 2 used in test I was 1/200 the amount obtained from 64 · 
spiders while toxin 1 was 1/250 the amount obtained from 100.spiders, In 
Test II toxin 2 was as in test I but toxin 1 was obtained by washing the 
tube which contained the small amount used in test I with 25 µl of saline 
and using 10 µl of the wash. 
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TABLE. XXVI 
EFFECT OF HEPARIN TREATMENT ON OXT CHALLENGE IN MICE. 
No. material No. dead No. dead 
of mice injected (i. p.) at 24 hr at 48 hr 
8 300 µg OXT 5 8 
8 4.25 units heparin; 300 µg 8 
OXT 30 min later 
2 4.25 units heparin 0 0 
Figure 42~ Fiow Diagram of OXT Fractionation With 
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doses of OXT. These were found whether the route was i.p. or s.c. No 
lesions.were found in the intestines of treated rabbits. "The effect of 
the OXT in rabbits appears to be localized at the site of .injection where 
it .acts directly on the mui;;cle, producing acute, calcified necrosis, 
The toxin, or its necrotic products, induce a major inflammatory reac""". 
tion, characterized by neutrophilic exudation. Many of the vessels are 
conjested and there is some evidence of thrombosis, No heart or kidney 
lesions were found in any of the specimens" (60). The intestinal lesions 
of mice found after OXT challenge by Dr. Ward were not sufficient damage 
to kill the mice in 48 hr. The means by which OXT produces death in test. 
animals is not known. 
CH.APTER IV 
SUMMARY 
An extract of the poison apparatus of .the brown recluse spider, 1.• 
reclusa, has been prepared which retains the.toxic biological activities 
of the venom. It is lethal to rabbits, mice and roaches, When injected 
i.d, or s.c. into. rabbits it produces necrotic lesions. These toxic.ef-
fects have been quantitated as to the amount of extract protein required. 
All 1n50 1 s are in the microgram range. The toxicity of the venom appara-
tus extract (OXT) is heat labilia but stable to freezing and thawing, 
Toxicity to mice can be destroyed by the action of proteases. Toxicity 
of the OXT is diminished in the presence of .phosphate or Tris buffers, 
The OXT contains hyaluronidase and phosphohydrolase enzyme activi-
ties. The phosphohydrolase has been characterized as a rather non-
specific, .heat stable, alkaline phosphohydrolase. No protease activity 
was found. Also, the OXT has no hemolytic activity with human or rabbit 
erythrocytes, but it does decrease the coagulation time of ht,iman.plasma. 
The OXT has been fractionated by molecular exclusion chromatography, 
preparative polyacrylamide discontinuous. electrophoresis, paper chroma-
tography and ion exchange chromatography. Three toxic components have 
been identified. The component which is toxic to roaches has a molecu-
lar weight of (>,800 as detenninec:l by Sephadex column chromatography, 
The mammalian toxins, toxins 1 and 2, both have molecular weights of 
approximately 32 to 34,000 as determined by.SDS polyacrylamide gel. 
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electrophoresis and Sephadex column chromatography, Both toxins appear 
to be electrophoretically homogeneous. proteins. The isoelectric .pH of 
both , as determined by isoelectric focusing is 8 •. 3. Amino .acid . analyses . 
of toxins .1 and. 2 have been obtained. Small amounts of toxin 1 cause 
lesions in rabbits. Larger amounts of toxin 1 are lethal to both mice· 
and rabbits. Toxin 2 is letha~ to rabbits but; appears.nontoxic to mice. 
Neithe.r of ,the toxins has hyaluronidase or phosphohydrolase activity, . 
but toxin 1 has .the plasma coagulat;ing activity. This suggests that the. 
cause of the necrotic lesion .is local blood clotting, as was ·earlier. 
proposed by researchers at .the Univez:sity of Missouri, Future work will 
involve elucidation of the effect of toxin 1 on the .blood clotting 
mechanism. 
Antisera to toxin 1, toxin 2, and·OXT have been prepared. The 
presence of antibodies was. conf i.rmed, with immunodiffusion, inununoelectro-
phoresis and red blood cell agglutination techniques. None of the anti-
: I . 
sera were effective (as tested) in preventing toxic effects of the OXT 
in rabbits. Anti 1 appears to protect miqe against the.immediate letqal 
ef.fects of .the OXT. 
The OXT contains a nUII1,ber of nontox:l,c "nucleotid~-like" components 
which were partially characterized by paper and·ion exchange chromato-
graphy and UV spectrophotometry. Only inosine was positively identifi-
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